Vident Investment Advisory, LLC Pfizer Inc Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $5.83 Million - $6.75 Million	-161,452 Reduced 34.0%	313,470 $11.5 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $877,845 - $1.14 Million	-22,286 Reduced 4.48%	474,922 $19.4 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $10.4 Million - $13.5 Million	248,394 Added 99.83%	497,208 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.88 Million - $2.3 Million	42,999 Added 20.89%	248,814 $9.55 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $684,409 - $811,495	14,709 Added 7.7%	205,815 $10.8 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $2.49 Million - $3.08 Million	54,323 Added 39.71%	191,106 $9.89 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $73,673 - $109,208	-1,783 Reduced 1.29%	136,783 $8.08 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $2.09 Million - $2.69 Million	53,266 Added 62.45%	138,566 $5.96 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $1.13 Million - $1.28 Million	31,369 Added 58.17%	85,300 $3.34 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $1.58 Million - $1.78 Million	-47,081 Reduced 46.61%	53,931 $1.95 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $1,037 - $1,319	-31 Reduced 0.03%	101,012 $3.72 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $1.35 Million - $1.59 Million	42,571 Added 72.81%	101,043 $3.71 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $7.74 Million - $9.39 Million	-257,098 Reduced 81.47%	58,472 $1.91 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $8.13 Million - $9.86 Million	269,789 Added 589.3%	315,570 $10.3 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $1.26 Million - $1.81 Million	-46,797 Reduced 50.55%	45,781 $1.5 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $1.83 Million - $2.08 Million	55,674 Added 150.86%	92,578 $3.63 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $397,287 - $515,165	-12,228 Reduced 24.89%	36,904 $1.33 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $2.6 Million - $2.92 Million	-70,394 Reduced 58.89%	49,132 $2.13 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $48,825 - $53,642	-1,302 Reduced 1.08%	119,526 $5.08 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $94,751 - $108,027	2,463 Added 2.08%	120,828 $5.27 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $155,838 - $189,023	-4,521 Reduced 3.68%	118,365 $5.22 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $36,146 - $38,535	1,096 Added 0.9%	122,886 $4.46 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $2.58 Million - $2.99 Million	80,765 Added 196.87%	121,790 $4.46 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $136,499 - $144,830	4,104 Added 11.12%	41,025 $1.49 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $1.14 Million - $1.26 Million	36,921	36,921 $1.32 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$14 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.7 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.88 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.57 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.22 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account